Literature DB >> 9562261

Expression of three calpain isoform genes in human skeletal muscles.

H Ueyama1, T Kumamoto, S Fujimoto, T Murakami, T Tsuda.   

Abstract

Calpain is thought to be involved in muscular degradation in progressive muscular dystrophy (PMD), especially Duchenne and Becker muscular dystrophies. To assess the expression of calpain genes in skeletal muscles of patients with myopathies, we examined mRNA levels of three calpain isoforms by the quantitative reverse transcriptase-polymerase chain reaction method in biopsied muscles from control, PMD and amyotrophic lateral sclerosis (ALS) patients. There was a statistically significant increase in calpain 1 and calpain 2 mRNA levels in PMD and ALS patients as compared to controls. In contrast, there was a decrease in expression of calpain 3 mRNA in PMD, but it was not statistically significant. Expression of calpain 1 and calpain 2 positively correlated with each other, but not with calpain 3. These results indicate that expression of calpain 1 and calpain 2, but not calpain 3, are upregulated in diseased human muscles, likely playing a regulatory role in the process of myofibrillar degradation at the transcriptional as well as posttranslational level.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562261     DOI: 10.1016/s0022-510x(97)00309-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle.

Authors:  L Féasson; D Stockholm; D Freyssenet; I Richard; S Duguez; J S Beckmann; C Denis
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

2.  Transforming growth factor betas are upregulated in the rat masseter muscle hypertrophied by clenbuterol, a beta2 adrenergic agonist.

Authors:  Satonari Akutsu; Akemi Shimada; Akira Yamane
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  Differential role of calpain-dependent protein cleavage in intermediate and long-term operant memory in Aplysia.

Authors:  Lisa C Lyons; Jacob S Gardner; Cassidy T Lentsch; Catherine E Gandour; Harini C Krishnan; Eric J Noakes
Journal:  Neurobiol Learn Mem       Date:  2016-11-29       Impact factor: 2.877

Review 4.  The key role of Calpain in COVID-19 as a therapeutic strategy.

Authors:  Aref Doozandeh Juibari; Mohammad Hossein Rezadoost; Masoud Soleimani
Journal:  Inflammopharmacology       Date:  2022-05-30       Impact factor: 5.093

5.  Calpain inhibition protects spinal motoneurons from the excitotoxic effects of AMPA in vivo.

Authors:  Juan Carlos Corona; Ricardo Tapia
Journal:  Neurochem Res       Date:  2008-01-25       Impact factor: 3.996

6.  Fibrosis, adipogenesis, and muscle atrophy in congenital muscular torticollis.

Authors:  Huan-Xiong Chen; Sheng-Ping Tang; Fu-Tang Gao; Jiang-Long Xu; Xian-Ping Jiang; Juan Cao; Gui-Bing Fu; Ke Sun; Shi-Zhe Liu; Wei Shi
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

7.  Orai1 mediates exacerbated Ca(2+) entry in dystrophic skeletal muscle.

Authors:  Xiaoli Zhao; Joseph G Moloughney; Sai Zhang; Shinji Komazaki; Noah Weisleder
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

8.  Role of calpain in apoptosis.

Authors:  Hamid Reza Momeni
Journal:  Cell J       Date:  2011-08-24       Impact factor: 2.479

9.  Ezrin regulates focal adhesion and invadopodia dynamics by altering calpain activity to promote breast cancer cell invasion.

Authors:  Victoria Hoskin; Alvin Szeto; Abdi Ghaffari; Peter A Greer; Graham P Côté; Bruce E Elliott
Journal:  Mol Biol Cell       Date:  2015-08-05       Impact factor: 4.138

10.  Differential expression of apoptosis-related factors induces the age-related apoptosis of the gracilis muscle in humans.

Authors:  Soo Yeon Park; Jung Hwan Lee; Ha Young Kim; Kyoung Ho Yoon; Seong Kyu Park; Mun Seog Chang
Journal:  Int J Mol Med       Date:  2014-02-27       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.